Breast cancer publication network: profile of co-authorship and co-organization

Introduction: Breast cancer is one of the highest reasons of deaths for people in the world. The objective of current study is to analyze and visualize the trend of global scientific activities in the field of breast cancer during a period of 10 years through 2006-2015. Methods: The current study was performed by utilizing the scientometrics analysis and mapping the co-authorship and co-organization networks. The Web of Science Core Collection (WoS-CC)database was used to extract all papers indexed as a topic of breast cancer through 2006 to 2015. Research productivity was measured through analysis several parameters, including: the number and time course of publications, the journal and language of publications, the frequency and type of publications, as well as top 20 active sub-categories together with country contribution. The extracted data were transferred into the Excel charts and plotted as diagrams. The Science of Science (Sci2) and CiteSpace softwares were used as tools for mapping the co-authorship and co-organization networks of the published papers. Results: Analysis of data indicated that the number of publications in the field of breast cancer has linearly increased and correlated with the time-course of the study. The number of publication indexed in WoS-CC in 2015 was two times greater than that of 2006, which reached from 15 229 documents in 2006 to 30 667 documents in 2015. English Language accounted for 98% of total publications as the most dominant language. The vast majority of publications' type was in the form of original journal articles (64.7%). Based on Bradford scatterings law, the journal of "Cancer Research" was the most productive journal among the core journals, while the USA, China, and England were the most prolific countries in the field. The co-organization network indicated the dominant role of Harvard University in the field. Conclusion: The integrity of network indicated that scientists in the field of breast cancer working collaboratively to tackle the number one threat in women health.